The results of the study, "Impact of a Shielded Safety Syringe on Needlestick Injuries Among Healthcare Workers," in the June 1992 issue (1992;13:349-353) are encouraging. Technology that keeps the worker's hands behind the needle at all times and covers the needle after use should significantly lower the rate of needlestick injuries.
However, we noted the following inconsistencies between the data reported in the Study Phase column of Table 1 and 2:  Table 1 lists the number of needlesticks from prefilled cartridge, injection syringes as 11 during the study phase. However, in Table 2 the total number of needlesticks from this device at the three hospital sites is zero.
During the study phase, Table 1 reports 28 total injuries from IV/IV piggyback devices while the total number in Table 2 is 29. Table 1 records 5 lancet injuries during the study phase; the corresponding total number of lancet injuries is 4 in Table 2 .
The Study Phase Column of Table 1 lists 36 injuries with miscellaneous syringes, needles, and catheters. The same category total in Table 2 is 37.
Accurate information is essential to determine the impact of new technology on healthcare worker protection. This study is a step forward in our understanding of one potentially important needle The authors reply. Table 1 should read as indicated.
Letters to the Editor
All of Table 2 is correct. In the abstract, the source identification number reads 1993; it should be 1992.
mented that the incidence of methicillin-resistant Staphylococcus aureus (MRSA) is increasing in acute-care hospitals.1~2 Although comparable data are not available for skilled nursing facilities, there is little doubt that MRSA is being encountered with increased frequency in nursing home patients. As a result, many skilled nursing facilities have questions about the infection control measures that should be used when MRSA occurs among nursing home residents. It's the full line of KIMBERLY-CLARKTM Personal Protective Equipment. When you are choosing the appropriate protection to comply with OSHA requirements, this proven line can help you with a full range of options that can provide both confidence and comfort.
Only Kimberly-Clark offers a patented 3-layer fabric construction. So you can have community skilled nursing facilities. Presently, our understanding of the risks of MRSA colonization and infection in nursing home residents is based primarily on the results of a few careful studies performed in Veterans Affairs (VA) nursing home units.3-6 However, it should be emphasized that the findings in VA-affiliated nursing home units may not accurately reflect the epidemiology of MRSA in community skilled nursing facilities. Nonetheless, these studies have yielded useful data regarding some of the issues raised in Dr. Silver's letter.
In all types of facilities, a patient who is culture-positive for MRSA at any body site, and who has no signs or symptoms of infection at the affected site is considered to be colonized with MRSA. In prospective culture surveys performed in VA-affiliated nursing home units, from 4% to 10% of residents acquired MRSA over the course of one year.4,5 However, because residents may reside for extended periods of time in the same facility, the number of culture-positive patients residing in a facility may gradually increase over time so that the proportion of residents who are colonized may reach 5% to 10% in communitybased nursing homes and 25% to 35% in VA-affiliated nursing home units.315, 7 Residents with wounds (e.g., gastrointestinal tube sites or decubitus ulcers) or indwelling vascular or bladder catheters, and those with the greatest degree of functional impairment are at greatest risk of acquiring MRSA.3,5,7 Although roommates of residents with MRSA were thought to be at high risk of acquiring MRSA, studies in a VA-affiliated nursing unit and in a community-based nursing home found that only a few percent of exposed residents acquired the same strain of MRSA as their roommate.5T7
Because roommate-to-roommate transmission appears to be uncommon and private rooms are seldom available in skilled nursing facilities, it is neither practical nor necessary to place all residents with MRSA in a private room. In such facilities, cohorting of patients with MRSA is reasonable but should not be considered mandatory. If cohorting is not practical, the best roommate for a patient with MRSA would be an individual who is ambulatory and has no wounds or indwelling catheters.
With any strain of S aureus, whether it is methicillin-susceptible or methicillin-resistant, some individuals carry the organism for only a few days, some will carry it for several weeks and then cease to be carriers, and some will remain persistently colonized for proven resistance to blood strikethrough * as well as breathability. This means that in many usage situations, there is no need to endure the discomfort of hot plastic. our PARTNERS IN QUALITY" Line. Call 1-800-KC-HELPS and our nurse specialists will be glad to provide you information on the OSHA Final Rule and on Kimberly-Clark products. In addition to a full range of sizes in surgical gowns, cover gowns, headwear, footwear and lab aDoare1. Kimberlv-Clark has another line that Sin ease the challenge of compliance. It's @ Kimberly-Clark How serious a threat does MRSA pose to residents in skilled nursing facilities? Several studies have shown that only 1% to 3% of all residents in the affected nursing home units developed an infection due to MRSA.4,5 Among residents who were known to be lowup periods of one to two colonized with MRSA, 6% to 14% months.6J2 Because the incidence developed an infection due to of MRSA infection was already low MRSA. This is in marked contrast in these facilities, widespread use to colonized hospitalized patients, of decolonization regimens did not who have a 30% to 60% chance of lead to a significant reduction in developing a MRSA infection.li In the incidence of MRSA infec-VA-affiliated nursing home units tions.6J2 Of additional concern, where careful surveillance was conresistance to the antimicrobial ducted, few deaths resulted from agents used developed in both stud-MRSA infection.s5
ies. Routine treatment of all colonized residents with topical or oral antibiotic regimens designed to eradicate MRSA is not recommended.4+j In VA-affiliated nursing home units where topical mupirocin or oral regimens were used widely, only modest reductions in the prevalence of MRSA colonization were achieved.
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